Uncategorized Archives - Page 76 of 87 - PsychedelicNewsWire (PNW)

ThursdayJul 25, 2019 10:22 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Agreement Increases Reach of Ingested Cannabis Absorption Technology

Cannabis users have historically preferred to inhale smoke from the burned plant in order to achieve rapid-onset absorption of its properties, but Lexaria Bioscience is making it possible to achieve similar results through oral ingestion Lexaria’s revolutionary DehydraTECH technology allows cannabis users to eliminate the unhealthy effects of smoking from their routines, and the product is being tested with nicotine as well Cannabis-infused edibles sales are expected to climb from about $1 billion currently to about $4.1 billion by 2022 Consumable bioactive product innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) will expand the reach of its revolutionary DehydraTECH technology…

MondayJul 08, 2019 10:12 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Leading the Way in Effective Cannabis Treatment

Lexaria developed and out-licenses DehydraTECH to create new (and improve existing) drug-delivery products The company is credited with leading the way forward in discovering new ways to effectively deliver CBD into the human body Lexaria is helping firms meet supply and demand requirements by creating products that offer lower dosing with higher absorption Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is known for its innovative delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. The company developed drug-delivery platform DehydraTECH and out-licenses the platform to create new (and improve existing) orally ingested…

MondayJun 10, 2019 11:22 am

Hemptown USA Leveraging Leading Genetics to Increase Yields and Expand into Novel Cannabinoids

Hemp seed genetics are critical to hemp farming success Cannabigerol (CBG) is emerging as a valuable cannabinoid with multiple potential health benefits Hemptown USA is growing one million rare cannabigerol-dominant plants designed to yield up to one million pounds of CBG biomass High quality seeds are a key prerequisite for growing healthy, strong cannabis plants. The right seeds can deliver the right cannabinoid profile, increase resilience and help for achieving sufficiently sustainable yields. Companies like Hemptown USA are pioneers in the farming of novel cannabinoid strains in addition to cannabidiol (CBD). In 2019, the company acquired $5.5 million worth of…

TuesdayJun 04, 2019 12:01 pm

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is “One to Watch”

H1 2019 results reflect excellent operational execution: lowest cost of cultivation per gram among publicly reporting Canadian LPs, industry-leading adjusted gross margin and adjusted EBITDA (positive adjusted EBITDA for 3rd consecutive quarter in Q2 2019) On track to increase target production capacity to 113,000 kg/year by the end of 2019 Well-positioned for Canada’s new edibles and derivative legalization expected in October 2019 with expanding production capacity, R&D and various strategic partnerships Invested in biosynthesis to produce cannabinoids without growing the plant at a fraction of cultivation costs Focused on developing further international partnerships, prioritizing the CBD market Organigram Holdings Inc.…

MondayMay 06, 2019 10:59 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters New Licensing Agreement, Strengthens Business Model

Lexaria continues to create a strong, revenue-generating business model to support its growing patent portfolio The company out-licenses disruptive delivery technology, giving licensees access to existing patents Lexaria entered into a new beverage license agreement with a California-based cannabis firm The company recently announced four new appointments to its scientific advisory board Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a drug-delivery platform innovator with existing cannabinoid licensing agreements in Canada and the United States, as well as internationally. By out-licensing disruptive delivery technology DehydraTECH, the company has created a strong, revenue-generating business model and a growing patent portfolio. At…

MondayApr 15, 2019 12:14 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Advancing DehydraTECH Drug Delivery Platform, Innovative Products

Lexaria Bioscience is focusing on its pioneering DehydraTECH drug delivery technology The company boasts a portfolio of unique products Lexaria continues to conduct research regarding DehydraTECH technology for oral nicotine Based in Kelowna, British Columbia, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) focuses on technology for the improved delivery of bioactive compounds. Lexaria is the only global company with patents issued for the oral delivery of all cannabinoids. The company has developed and out-licenses its innovative and cost-effective DehydraTECH drug delivery platform. This technology changes the way that edible cannabinoids enter the body. DehydraTECH delivery technology offers a viable and…

TuesdayApr 09, 2019 10:32 am

VPR Brands, LP (VPRB) is “One to Watch”

Diversified product lines, new sales channels and distributors, an expanded sales team, and increasing social awareness of VPR Brands has increased profit margins GoldLine CBD product division increases target market and potential customers in the consumable supplements and nutraceuticals sectors Cutting-edge technology and user-centric designs uniquely engineered to be used with cannabis or CBD oils, concentrates and flowers Private label (white label) business is a growth sector; in 2018 VPR Brands white labeled several award-winning vaporizers for prominent companies Required testing and certification to allow all VPR Brand products to be imported and sold in the European Union is underway…

TuesdayMar 26, 2019 11:56 am

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Revolutionary Technology is Disrupting the Cannabis Edibles Industry

Lexaria Bioscience Corp. is the only company worldwide with patents issued for oral delivery of all cannabinoids Its proprietary technology bests traditional methods such as inhalation in several key ways The company continues to enhance its intellectual property portfolio as it pursues patents around the world Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a food biosciences company, has developed a proprietary technology that has revolutionized the way cannabidiol (CBD) and other non-psychoactive cannabinoids are delivered into the bloodstream. Lexaria, the only company worldwide with patents issued for oral delivery of all cannabinoids, has greatly improved the delivery of bioactive compounds.…

TuesdayMar 12, 2019 12:31 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Innovating on Numerous Fronts with DehydraTECH Drug Delivery Platform

Lexaria Bioscience is focusing on its unique technology for the delivery of bioactive compounds The company’s concentration on oral ingestion results in an option that often healthier than other delivery methods Its DehydraTECH technology has potential applications for nicotine absorption Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) focuses on technology for the improved delivery of bioactive compounds. Its DehydraTECH drug delivery platform fosters healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules. The company’s process changes the way edible cannabinoids enter the body (http://cnw.fm/s5uPI). A drug delivery innovator, Lexaria Bioscience is headquartered in Kelowna,…

FridayMar 01, 2019 12:53 pm

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Does Not Irradiate its Cannabis; 80 Percent of LPs Do

Clean, controlled cultivation eschews use of radiation to destroy pests and pathogens Analysts at Jefferies recently initiated coverage of FLWR Flowr has applied for Nasdaq Listing The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) is growing cannabis with TLC as well as THC. The Health Canada Licensed Producer (“LP”) of cannabis, founded by MedReleaf co-founder Tom Flow and a team of industry pioneers, is out to generate premium, non-irradiated product at high yields. The company expects its ability to produce clean cannabis at consistently high quality to be a crucial differentiating factor as the medical and recreational markets in Canada develop. Its…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Uncategorized